Antigen processing and presentation by the class I major histocompatibility complex.

Major histocompatibility complex (MHC) class I molecules bind peptides derived from cellular proteins and display them for surveillance by the immune system. These peptide-binding molecules are composed of a heavy chain, containing an antigen-binding groove, which is tightly associated with a light chain (beta 2-microglobulin). The majority of presented peptides are generated by degradation of proteins in the cytoplasm, in many cases by a large multicatalytic proteolytic particle, the proteasome. Two beta-subunits of the proteasome, LMP2 and LMP7, are inducible by interferon-gamma and alter the catalytic activities of this particle, enhancing the presentation of at least some antigens. After production of the peptide in the cytosol, it is transported across the endoplasmic reticulum (ER) membrane in an ATP-dependent manner by TAP (transporter associated with antigen presentation), a member of the ATP-binding cassette family of transport proteins. There are minor pathways for generating presented peptides directly in the ER, and some evidence suggests that peptides may be further trimmed in this location. The class I heavy chain and beta 2-microglobulin are cotranslationally translocated into the endoplasmic reticulum where their assembly may be facilitated by the sequential association of the heavy chain with chaperone proteins BiP and calnexin. The class I molecule then associates with the lumenal face of TAP where it is retained, presumably awaiting a peptide. After the class I molecule binds a peptide, it is released for exocytosis to the cell surface where cytotoxic T lymphocytes examine it for peptides derived from foreign proteins.

[1]  A. Goldberg,et al.  Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. , 1995, Journal of immunology.

[2]  A. G. Grandea,et al.  Dependence of Peptide Binding by MHC Class I Molecules on Their Interaction with TAP , 1995, Science.

[3]  J. Yewdell,et al.  Assembly, Intracellular Localization, and Nucleotide Binding Properties of the Human Peptide Transporters TAP1 and TAP2 Expressed by Recombinant Vaccinia Viruses (*) , 1995, The Journal of Biological Chemistry.

[4]  C. Harding,et al.  Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. , 1995, Journal of immunology.

[5]  R. Siliciano,et al.  MHC class I-restricted processing of transmembrane proteins. Mechanism and biologic significance. , 1995, Journal of immunology.

[6]  J. Scott,et al.  MHC class I expression and transport in a calnexin-deficient cell line. , 1995, Journal of immunology.

[7]  T. Braciale,et al.  Why can't cytotoxic T cells handle HIV? , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. A. Peterson,et al.  A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.

[9]  R. Siliciano,et al.  An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL. , 1995, Journal of Immunology.

[10]  J. Yewdell,et al.  Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.

[11]  B. Carreno,et al.  Aglycosylated and phosphatidylinositol-anchored MHC class I molecules are associated with calnexin. Evidence implicating the class I-connecting peptide segment in calnexin association. , 1995, Journal of Immunology.

[12]  R F Standaert,et al.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin , 1995, Science.

[13]  B. Carreno,et al.  Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin. , 1995, Molecular immunology.

[14]  R. Huber,et al.  Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. , 1995, Science.

[15]  W Baumeister,et al.  Proteasome from Thermoplasma acidophilum: a threonine protease. , 1995, Science.

[16]  T. Elliott,et al.  Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum , 1995, The Journal of experimental medicine.

[17]  M R Jackson,et al.  The Molecular Chaperone Calnexin Binds Glc1Man9GlcNAc2 Oligosaccharide as an Initial Step in Recognizing Unfolded Glycoproteins (*) , 1995, The Journal of Biological Chemistry.

[18]  H. Ploegh,et al.  Peptide influences the folding and intracellular transport of free major histocompatibility complex class I heavy chains , 1995, The Journal of experimental medicine.

[19]  K Eichmann,et al.  Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. , 1995, Immunity.

[20]  R. Salter,et al.  Calnexin Recognizes Carbohydrate and Protein Determinants of Class I Major Histocompatibility Complex Molecules (*) , 1995, The Journal of Biological Chemistry.

[21]  M. Feltkamp,et al.  Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. , 1995, Journal of immunology.

[22]  J. Yewdell,et al.  Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. , 1995, Immunity.

[23]  T. Watts,et al.  Molecular chaperones in antigen presentation. , 1995, Current opinion in immunology.

[24]  T. Elliott,et al.  Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport , 1995, European journal of immunology.

[25]  E. Adams,et al.  The Origins of HLA‐A,B,C Polymorphism , 1995, Immunological reviews.

[26]  J. Howard Supply and transport of peptides presented by class I MHC molecules. , 1995, Current opinion in immunology.

[27]  B. Murphy,et al.  Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus , 1995, Journal of virology.

[28]  N. Shastri,et al.  Major Histocompatibility Class I Molecules Can Present Cryptic Translation Products to T-cells (*) , 1995, The Journal of Biological Chemistry.

[29]  M. Rechsteiner,et al.  Effects of interferon gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Yewdell,et al.  Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines. , 1995, Journal of immunology.

[31]  N. Shastri,et al.  The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes. , 1995, Journal of immunology.

[32]  C. Bona,et al.  Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant , 1995, The Journal of experimental medicine.

[33]  P. Parham,et al.  Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules , 1995, The Journal of experimental medicine.

[34]  J. Sacchettini,et al.  Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  P. van Endert,et al.  Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Schumacher,et al.  Transporters from H-2b, H-2d, H-2s, H-2k, and H-2g7 (NOD/Lt) haplotype translocate similar sets of peptides. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Demars,et al.  Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. , 1994, Journal of immunology.

[38]  H. Ploegh,et al.  Substrate specificity of allelic variants of the TAP peptide transporter. , 1994, Immunity.

[39]  J. Yewdell,et al.  Trimming of antigenic peptides in an early secretory compartment , 1994, The Journal of experimental medicine.

[40]  M. Brenner,et al.  An unstable beta 2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide , 1994, The Journal of experimental medicine.

[41]  J. Neefjes,et al.  Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling , 1994, The Journal of experimental medicine.

[42]  Edward J. Collins,et al.  Three-dimensional structure of a peptide extending from one end of a class I MHC binding site , 1994, Nature.

[43]  Aaron Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway , 1994, Cell.

[44]  W. Jefferies,et al.  Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing , 1994, The Journal of experimental medicine.

[45]  S. Tonegawa,et al.  Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.

[46]  A. Goldberg,et al.  Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Tampé,et al.  Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells , 1994, FEBS letters.

[48]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[49]  M. Zúñiga,et al.  Ab initio association with beta 2-microglobulin during biosynthesis of the H-2Ld class I major histocompatibility complex heavy chain promotes proper disulfide bond formation and stable peptide binding. , 1994, The Journal of biological chemistry.

[50]  J. Trowsdale,et al.  Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins , 1994, Current Biology.

[51]  J. Peters,et al.  Proteasomes: protein degradation machines of the cell. , 1994, Trends in biochemical sciences.

[52]  R. Tampé,et al.  A sequential model for peptide binding and transport by the transporters associated with antigen processing. , 1994, Immunity.

[53]  K. Tanaka,et al.  cDNA cloning and interferon gamma down-regulation of proteasomal subunits X and Y. , 1994, Science.

[54]  K. Rajewsky,et al.  MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.

[55]  P. A. Peterson,et al.  Nucleotide binding of the C‐terminal domains of the major histocompatibility complex‐encoded transporter expressed in Drosophila melanogaster cells , 1994, FEBS letters.

[56]  W. Baumeister,et al.  Existence of a molecular ruler in proteasomes suggested by analysis of degradation products , 1994, FEBS letters.

[57]  J. Salamero,et al.  Homozygous human TAP peptide transporter mutation in HLA class I deficiency. , 1994, Science.

[58]  D. Geraghty,et al.  A second lineage of mammalian major histocompatibility complex class I genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[59]  P. A. Peterson,et al.  Displacement of housekeeping proteasome subunits by MHC‐encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. , 1994, The EMBO journal.

[60]  Y. Murakami,et al.  ATP- and antizyme-dependent endoproteolysis of ornithine decarboxylase to oligopeptides by the 26 S proteasome. , 1994, The Journal of biological chemistry.

[61]  M. Brenner,et al.  Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum , 1994, The Journal of experimental medicine.

[62]  J. Salamero,et al.  Biogenesis of MHC class I antigens: involvement of multiple chaperone molecules. , 1994, European journal of cell biology.

[63]  P. A. Peterson,et al.  Interaction of MHC class I molecules with the transporter associated with antigen processing. , 1994, Science.

[64]  R. Tampé,et al.  Nucleotide binding to the hydrophilic C-terminal domain of the transporter associated with antigen processing (TAP). , 1994, The Journal of biological chemistry.

[65]  J. Neefjes,et al.  Peptide size selection by the major histocompatibility complex-encoded peptide transporter , 1994, The Journal of experimental medicine.

[66]  P. Cresswell,et al.  MHC class l/β2-microglobulin complexes associate with TAP transporters before peptide binding , 1994, Nature.

[67]  Clive A. Slaughter,et al.  Proteolytic Processing of Ovalbumin and β-galactosidase by the Proteasome to Yield Antigenic Peptides , 1994 .

[68]  P. Cresswell,et al.  Human transporters associated with antigen processing possess a promiscuous peptide-binding site. , 1994, Immunity.

[69]  P. Kourilsky,et al.  Role for MHC class I molecules in selecting and protecting high affinity peptides in the presence of proteases. , 1994, Journal of immunology.

[70]  A Sette,et al.  Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. , 1994, Journal of immunology.

[71]  Q. Deveraux,et al.  A 26 S protease subunit that binds ubiquitin conjugates. , 1994, The Journal of biological chemistry.

[72]  D. Y. Thomas,et al.  Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. , 1994, Trends in biochemical sciences.

[73]  P M Kloetzel,et al.  Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes , 1994, The Journal of experimental medicine.

[74]  Günter J. Hämmerling,et al.  Selectivity of MHC-encoded peptide transporters from human, mouse and rat , 1994, Nature.

[75]  K. Tanaka,et al.  Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. , 1994, Journal of biochemistry.

[76]  V. Engelhard Structure of peptides associated with MHC class I molecules. , 1994, Current opinion in immunology.

[77]  S. Tonegawa,et al.  Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator , 1994, The Journal of experimental medicine.

[78]  J. Yewdell,et al.  MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation. , 1994, Journal of immunology.

[79]  J. Neefjes,et al.  Peptide selection by MHC-encoded TAP transporters. , 1994, Current opinion in immunology.

[80]  M R Jackson,et al.  Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). , 1994, Science.

[81]  J. Neefjes,et al.  Folding and assembly of major histocompatibility complex class I heterodimers in the endoplasmic reticulum of intact cells precedes the binding of peptide , 1993, The Journal of experimental medicine.

[82]  A. R. Siddiqi,et al.  Major histocompatibility complex class I‐binding peptides are recycled to the cell surface after internalization , 1993, European journal of immunology.

[83]  H. Eisen,et al.  A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[84]  D. Wiley,et al.  The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.

[85]  R. Henderson,et al.  Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[86]  P. Cresswell,et al.  Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[87]  A. Goldberg,et al.  Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. , 1993, Nature.

[88]  D. Finley,et al.  MHC-linked LMP gene products specifically alter peptidase activities of the proteasome , 1993, Nature.

[89]  P. H. Cameron,et al.  Association of folding intermediates of glycoproteins with calnexin during protein maturation , 1993, Nature.

[90]  R. Flavell,et al.  Identification of the region on the class I histocompatibility molecule that interacts with the molecular chaperone, p88 (calnexin, IP90). , 1993, The Journal of biological chemistry.

[91]  S. Tonegawa,et al.  TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective , 1993, Cell.

[92]  J. Neefjes,et al.  Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. , 1993, Science.

[93]  D. Feuerbach,et al.  Novel proteins associated with MHC class I antigens in cells expressing the adenovirus protein E3/19K. , 1993, The EMBO journal.

[94]  A. Goldberg,et al.  A role for the ubiquitin-dependent proteolytic pathway in MHC class l-restricted antigen presentation , 1993, Nature.

[95]  J. Yewdell,et al.  Class I molecules retained in the endoplasmic reticulum bind antigenic peptides , 1993, The Journal of experimental medicine.

[96]  D. Fremont,et al.  Structural analysis of MHC class I molecules with bound peptide antigens. , 1993, Seminars in immunology.

[97]  K. F. Lindahl,et al.  Peptide antigen presentation by non-classical MHC class I molecules , 1993 .

[98]  M. Rechsteiner,et al.  The multicatalytic and 26 S proteases. , 1993, The Journal of biological chemistry.

[99]  B. Walker,et al.  Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. , 1993, Journal of immunology.

[100]  J. Trowsdale,et al.  The transporters associated with antigen presentation. , 1993, Seminars in cell biology.

[101]  J. Neefjes,et al.  Cell biology of antigen presentation. , 1993, Current opinion in immunology.

[102]  S. Tonegawa,et al.  TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells , 1992, Cell.

[103]  J. Yewdell,et al.  Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes , 1992, Cell.

[104]  P. Bjorkman,et al.  Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. , 1992, Science.

[105]  P. Cresswell,et al.  Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules , 1992, Nature.

[106]  J. Neefjes,et al.  Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation , 1992, Nature.

[107]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[108]  C. Rice,et al.  CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope , 1992, The Journal of experimental medicine.

[109]  W. Lie,et al.  Extensive peptide ligand exchange by surface class I major histocompatibility complex molecules independent of exogenous beta 2-microglobulin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[110]  S. Jentsch,et al.  In vivo function of the proteasome in the ubiquitin pathway. , 1992, The EMBO journal.

[111]  U. Kubitscheck,et al.  Peptide Binding to Class I Molecules of the Major Histocompatibility Complex on the Surface of Living Target Cells , 1992, Scandinavian journal of immunology.

[112]  H. Ploegh,et al.  Peptide-induced stabilization and intracellular localization of empty HLA class I complexes , 1992, The Journal of experimental medicine.

[113]  R. Germain,et al.  Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression. , 1992, Journal of immunology.

[114]  A. Goldberg,et al.  Proteolysis, proteasomes and antigen presentation , 1992, Nature.

[115]  H. Ploegh,et al.  The fate of the three subunits of major histocompatibility complex class I molecules , 1992, European journal of immunology.

[116]  E. Degen,et al.  Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2- microglobulin and peptide , 1992, The Journal of experimental medicine.

[117]  J. Slot,et al.  Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi , 1992, Nature.

[118]  P. Walter,et al.  Evidence for peptide transport across microsomal membranes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[119]  D. Margulies,et al.  Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[120]  R. Henderson,et al.  HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. , 1992, Science.

[121]  K. Rock,et al.  Chemical cross-linking of class I molecules on cells creates receptive peptide binding sites. , 1992, Journal of immunology.

[122]  J. Yewdell,et al.  Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes , 1992, The Journal of experimental medicine.

[123]  W. Lie,et al.  Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: comparisons of peptide binding to alternative forms of Ld in cell lysates and the cell surface , 1992, The Journal of experimental medicine.

[124]  F. Lévy,et al.  Translocation of peptides through microsomal membranes is a rapid process and promotes assembly of HLA-B27 heavy chain and beta 2- microglobulin translated in vitro , 1991, The Journal of cell biology.

[125]  F. Lévy,et al.  ATP is required for in vitro assembly of MHC class I antigens but not to transfer of peptides acrosss the ER membrane , 1991, Cell.

[126]  D. R. Madden,et al.  The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.

[127]  L. Sherman,et al.  Exogenous β2‐microglobulin is required for antigenic peptide binding to isolated class I major histocompatibility complex molecules , 1991 .

[128]  J. Lippincott-Schwartz,et al.  Degradation of proteins within the endoplasmic reticulum. , 1991, Current opinion in cell biology.

[129]  P. Cresswell,et al.  Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I- restricted cell-mediated lysis , 1991, The Journal of experimental medicine.

[130]  M. Luscher,et al.  Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis , 1991, Nature.

[131]  T. Elliott,et al.  Peptide-induced conformational change of the class I heavy chain , 1991, Nature.

[132]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[133]  K. Rock,et al.  Dissociation of β 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface , 1991, Cell.

[134]  K. Rock,et al.  Low temperature and peptides favor the formation of class I heterodimers on RMA-S cells at the cell surface. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[135]  P. Parham,et al.  Peptide binding to empty HLA-B27 molecules of viable human cells , 1991, Nature.

[136]  V. Ortiz-Navarrete,et al.  Surface appearance and instability of empty H-2 class I molecules under physiological conditions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[137]  J. Berzofsky,et al.  Excess β2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules , 1991, Nature.

[138]  Hans-Georg Rammensee,et al.  Cellular peptide composition governed by major histocompatibility complex class I molecules , 1990, Nature.

[139]  K. Rock,et al.  Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[140]  F. Lemonnier,et al.  β2-Microglobulin restriction of antigen presentation , 1990, Nature.

[141]  Hidde L. Ploegh,et al.  Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro , 1990, Cell.

[142]  Hidde L. Ploegh,et al.  Empty MHC class I molecules come out in the cold , 1990, Nature.

[143]  T. Elliott,et al.  Assembly of MHC class I molecules analyzed in vitro , 1990, Cell.

[144]  P. Cresswell,et al.  Presentation of viral antigen controlled by a gene in the major histocompatibility complex , 1990, Nature.

[145]  H. Ljunggren,et al.  Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.

[146]  A. Truneh,et al.  Differential half-life of major histocompatibility complex encoded class I molecules in T and B lymphoblasts. , 1989, Molecular immunology.

[147]  J. Rothman,et al.  Peptide binding and release by proteins implicated as catalysts of protein assembly. , 1989, Science.

[148]  J. Yewdell,et al.  Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. , 1989, Science.

[149]  S. Pääbo,et al.  Molecular analysis of H-2-deficient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis. , 1989, Journal of immunology.

[150]  J. Strominger,et al.  Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[151]  I. Dunham,et al.  Human major histocompatibility complex contains genes for the major heat shock protein HSP70. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[152]  A. Ciechanover,et al.  A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1. , 1988, The Journal of biological chemistry.

[153]  E. Yunis,et al.  Receptor-like nature of class I HLA: endocytosis via coated pits. , 1988, Journal of immunology.

[154]  B. Coupar,et al.  Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen , 1988, The Journal of experimental medicine.

[155]  M. Bevan,et al.  Introduction of soluble protein into the class I pathway of antigen processing and presentation , 1988, Cell.

[156]  H. Ploegh,et al.  Allele and locus‐specific differences in cell surface expression and the association of HLA class I heavy chain with β2‐microglobulin: differential effects of inhibition of glycosylation on class I subunit association , 1988, European journal of immunology.

[157]  J. Yewdell,et al.  Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. , 1988, Science.

[158]  R. Ahmed,et al.  Effective clearance of a persistent viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific bone marrow-derived cells , 1987, Journal of virology.

[159]  S. Hoffstein,et al.  Endocytosis and de novo expression of major histocompatibility complex encoded class I molecules: kinetic and ultrastructural studies. , 1987, European journal of cell biology.

[160]  M. A. Saper,et al.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens , 1987, Nature.

[161]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[162]  K. Gould,et al.  Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence , 1986, Nature.

[163]  A. Varshavsky,et al.  In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.

[164]  H. Mcdevitt,et al.  The LMP antigens: a stable MHC-controlled multisubunit protein complex. , 1986, Human immunology.

[165]  T. Braciale,et al.  Differences in antigen presentation to MHC class I-and class II- restricted influenza virus-specific cytolytic T lymphocyte clones , 1986, The Journal of experimental medicine.

[166]  A. McMichael,et al.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.

[167]  J. Davey,et al.  Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.

[168]  A. McMichael,et al.  Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells , 1984, Cell.

[169]  D. Tse,et al.  Spontaneous internalization of Class I major histocompatibility complex molecules in T lymphoid cells , 1984, The Journal of experimental medicine.

[170]  L. Gooding,et al.  Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. , 1983, Journal of immunology.

[171]  R. Demars,et al.  Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line. , 1983, Human immunology.

[172]  J. Yewdell,et al.  A viral polymerase involved in recognition of influenza virus-infected cells by a cytotoxic T-cell clone , 1982, Nature.

[173]  G. Ada,et al.  Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus , 1978, Nature.

[174]  B. Fowlkes,et al.  Selective events in T cell development. , 1994, Annual review of immunology.

[175]  D. Raulet MHC class I-deficient mice. , 1994, Advances in immunology.

[176]  G. Berke The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. , 1994, Annual review of immunology.

[177]  V. Engelhard,et al.  Structure of peptides associated with class I and class II MHC molecules. , 1994, Annual review of immunology.

[178]  J. Rodgers,et al.  Antigen presentation by major histocompatibility complex class I-B molecules. , 1994, Annual review of immunology.

[179]  R. Germain,et al.  The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.

[180]  J. Monaco,et al.  A molecular model of MHC class-I-restricted antigen processing. , 1992, Immunology today.

[181]  J. Monaco Major histocompatibility complex-linked transport proteins and antigen processing , 1992, Immunologic research.

[182]  J. Yewdell,et al.  Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. , 1992, Advances in immunology.

[183]  Haas Ig BiP―A heat shock protein involved in immunoglobulin chain assembly , 1991 .

[184]  A. Goldberg,et al.  Intracellular protein degradation in mammalian and bacterial cells. , 1974, Annual review of biochemistry.